This website uses cookies to enhance the user experience.
21st logo
||
C

CLAVICULA AS916 497 067

Limited company
Strandvegen 106 9006 TROMSØ, Norge

CLAVICULA AS

Operating
Drive fysioterapitjenester og andre helsetjenester, trening, utleie til helsevirksomhet og eksterne oppdrag som undervisning og foredrag samt det som naturlig tilhører dette. Samt deltagelse i andre selskaper.

Organization

Chairman of the board
Years since formation
11 years
since Dec 31, 2015
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
30
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Total operating income 2025
2,947,104
NOK
Annual total result 2025
-220,475
NOK
Total equity 2025
2,044,705
NOK
Last update: Jul 23, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-

Others

NameRoleShares
B
BOK AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
100 %
directly
Last update: Aug 13, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
30
100 %

Shares owned by the CLAVICULA AS

NameShare classTotal number of sharesShare
K
K24 TROMSØ NORD AS
Ordinary shares
60
60 %
A
A2T INVEST AS
Ordinary shares
30
50 %
A
ABEL TECHNOLOGIES AS
A-shares
8,000
0.52 %
A
ANDFJORD SALMON GROUP AS
Ordinary shares
470
< 0.01 %
V
VÅR ENERGI ASA
Ordinary shares
250
< 0.01 %
E
EQUINOR ASA
Ordinary shares
50
< 0.01 %
K
KONGSBERG GRUPPEN ASA
Ordinary shares
125
< 0.01 %
L
LYTIX BIOPHARMA ASA
Ordinary shares
1,500
< 0.01 %
Last update: Sep 25, 2026

Group structure

  • Total operating income 2025: NOK 2,947,104
    Operating profit 2025: NOK 667,210
    Employees: 0

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
2,947,104
2,987,650
2,563,926
2,204,762
1,888,529
Annual Total Result
-220,475
536,912
220,004
167,377
125,925
Total assets
3,429,973
3,768,842
3,452,333
2,743,604
1,883,733
Total liabilities
1,385,267
1,499,256
1,719,660
1,230,934
538,441
Total equity
2,044,705
2,269,586
1,732,674
1,512,669
1,345,292

P&L

Year20252024202320222021
Total operating income
2,947,104
2,987,650
2,563,926
2,204,762
1,888,529
Total operating costs
2,279,894
2,230,962
2,211,813
1,930,926
1,716,706
Operating result
667,210
756,687
352,113
273,837
171,823
Financial income/costs
-887,685
-67,874
-69,644
-58,990
-9,617
Profit before tax
-220,475
688,814
282,469
214,847
162,206
Total tax & extraordinary income/cost
0
151,902
62,465
47,470
36,281
Annual Total Result
-220,475
536,912
220,004
167,377
125,925

Balance overview

Year20252024202320222021
Total fixed assets
2,604,547
2,868,398
469,577
466,520
433,930
Total current assets
825,426
900,444
2,982,756
2,277,083
1,449,803
Total assets
3,429,973
3,768,842
3,452,333
2,743,604
1,883,733
Short term debt
342,795
465,900
411,312
335,094
263,441
Long term debt
1,042,472
1,033,356
1,308,348
895,840
275,000
Total liabilities
1,385,267
1,499,256
1,719,660
1,230,934
538,441
Contributed capital
30,000
30,000
30,000
30,000
30,000
Retained earnings
2,014,705
2,239,586
1,702,674
1,482,669
1,315,292
Total equity
2,044,705
2,269,586
1,732,674
1,512,669
1,345,292
Total equity and liabilities
3,429,973
3,768,842
3,452,333
2,743,604
1,883,733

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification